GR3033248T3 - Controlled release drug formulation. - Google Patents

Controlled release drug formulation.

Info

Publication number
GR3033248T3
GR3033248T3 GR20000400930T GR20000400930T GR3033248T3 GR 3033248 T3 GR3033248 T3 GR 3033248T3 GR 20000400930 T GR20000400930 T GR 20000400930T GR 20000400930 T GR20000400930 T GR 20000400930T GR 3033248 T3 GR3033248 T3 GR 3033248T3
Authority
GR
Greece
Prior art keywords
inner layer
drug formulation
water
drug
controlled release
Prior art date
Application number
GR20000400930T
Other languages
English (en)
Inventor
Keiji Fujioka
Takeshi Hirasawa
Masako Kajihara
Akihiro Sano
Shuichi Sugawara
Yosuke Urabe
Original Assignee
Dow Corning Asia Ltd
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Asia Ltd, Sumitomo Pharma filed Critical Dow Corning Asia Ltd
Publication of GR3033248T3 publication Critical patent/GR3033248T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
GR20000400930T 1993-12-27 2000-04-17 Controlled release drug formulation. GR3033248T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33146793A JP3720386B2 (ja) 1993-12-27 1993-12-27 薬物放出制御製剤

Publications (1)

Publication Number Publication Date
GR3033248T3 true GR3033248T3 (en) 2000-09-29

Family

ID=18243976

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400930T GR3033248T3 (en) 1993-12-27 2000-04-17 Controlled release drug formulation.

Country Status (15)

Country Link
US (1) US5851547A (el)
EP (1) EP0659406B1 (el)
JP (1) JP3720386B2 (el)
KR (1) KR100349960B1 (el)
CN (1) CN1107497C (el)
AT (1) ATE190836T1 (el)
AU (1) AU686713B2 (el)
CA (1) CA2139058C (el)
DE (1) DE69423582T2 (el)
DK (1) DK0659406T3 (el)
ES (1) ES2146633T3 (el)
GR (1) GR3033248T3 (el)
NZ (1) NZ277548A (el)
PT (1) PT659406E (el)
WO (1) WO1995017881A1 (el)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056734A (en) * 1997-02-07 2000-05-02 Sarcos Lc Method for automatic dosing of drugs
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
DE69833375D1 (de) 1997-06-04 2006-04-13 Debio Rech Pharma Sa Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
TW586944B (en) * 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
US20020087184A1 (en) * 1998-06-18 2002-07-04 Eder Joseph C. Water-soluble coating for bioactive devices
BR9913596B1 (pt) * 1998-09-10 2014-12-23 Dainippon Sumitomo Pharma Co Composição farmacêutica de liberação prolongada de droga com longa duração.
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
JP2002542183A (ja) 1999-04-16 2002-12-10 ノボ ノルディスク アクティーゼルスカブ 成形可能な乾燥した医薬製剤
KR20020066320A (ko) * 1999-08-25 2002-08-14 조지타운 유니버시티 공동 시드, 바람직하게는 금속을 포함하여 이루어지는치료용 전달 시스템 및 이의 용도
TW524696B (en) 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
JP2002003406A (ja) * 2000-06-21 2002-01-09 Sankyo Co Ltd 脳血管攣縮予防製剤
WO2002005744A1 (en) * 2000-07-14 2002-01-24 Novo Nordisk A/S Method of moulding a pharmaceutical composition in a packaging material
CA2451187C (en) 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
JP2005522418A (ja) * 2002-01-24 2005-07-28 スマート ドラッグ システムズ インコーポレイティド 徐放性医薬組成物
JP4026745B2 (ja) * 2002-03-26 2007-12-26 財団法人大阪産業振興機構 医療用システムおよびその製造方法
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
PT2561860T (pt) 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
CA2520613C (en) 2003-03-31 2012-12-04 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of dopamine agonist
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
WO2004110400A2 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
PT1638535E (pt) * 2003-06-26 2007-11-08 Mediolanum Pharmaceuticals Ltd Implantes subcutâneos com libertação inicial de princípio activo limitada e subsequente sua libertação extensiva com variação linear
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
ATE508750T1 (de) * 2005-12-12 2011-05-15 Women And Infants Hospital Of Rhode Island Derivate von vitamin d und ihre verwendung in der therapie
US20080081064A1 (en) * 2006-09-28 2008-04-03 Surmodics, Inc. Implantable Medical Device with Apertures for Delivery of Bioactive Agents
WO2008070557A2 (en) * 2006-12-01 2008-06-12 Women & Infants Hospital Organometallic complexes as therapeutic agents
US20080153906A1 (en) * 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
WO2008091946A2 (en) 2007-01-24 2008-07-31 Women & Infants Hospital N-amino tetrahydrothiazine derivatives, method of manufacture and use
AR066166A1 (es) 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
CN102333544A (zh) 2009-02-06 2012-01-25 通用医疗公司 治疗血管损伤的方法
EP2246063A1 (en) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. Sustained release formulations comprising GnRH analogues
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
CN103124565A (zh) 2010-08-06 2013-05-29 大日本住友制药株式会社 用于控制水溶性药物释放的药物制剂
CN103140226B (zh) 2010-08-06 2015-07-08 大日本住友制药株式会社 用于治疗脊髓损伤的制剂
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
EP2911623B1 (en) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
JP6359390B2 (ja) * 2014-09-05 2018-07-18 テルモ株式会社 インプラントデバイスおよびインプラントデバイス植え込み具
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
KR102637575B1 (ko) * 2016-10-05 2024-02-20 타이탄 파머슈티컬즈 인코퍼레이티드 버스트 방출이 감소된 약물 전달용 이식 가능한 장치
CN112638400A (zh) * 2018-06-25 2021-04-09 泰坦医药品公司 用于释放亲脂性或两亲性药用物质的植入物
KR102442807B1 (ko) * 2021-01-29 2022-09-15 주식회사 티온랩테라퓨틱스 초기 방출 제어된 데포 조성물 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
FR2240817B1 (el) * 1973-08-16 1981-04-17 Roland Offsetmaschf
JPS5513381Y2 (el) * 1974-02-21 1980-03-26
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
JPS58781B2 (ja) * 1978-07-17 1983-01-07 風早 清志 畳表の自動裁断装置
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE3022800A1 (de) * 1980-06-19 1982-01-07 Bayer Ag, 5090 Leverkusen Verfahren zur temperaturregelung exothermer reaktionen durch ueberhitzung von wasserdampf
JPH0761959B2 (ja) * 1985-10-11 1995-07-05 住友製薬株式会社 シリコンエラストマ−系徐放性製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
ES2022454B3 (es) * 1986-06-17 1991-12-01 Recordati Ind Chimica E Farm S P A Sistema terapeutico para la liberacion controlada de drogas.
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
DK606288D0 (da) * 1988-03-24 1988-10-31 Bukh Meditec Praeparat
JPH02142738A (ja) * 1988-11-24 1990-05-31 Nippon Zeon Co Ltd 徐放性医薬製剤およびその製法
JP3118009B2 (ja) * 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤

Also Published As

Publication number Publication date
WO1995017881A1 (en) 1995-07-06
DE69423582T2 (de) 2000-09-07
DK0659406T3 (da) 2000-07-03
DE69423582D1 (de) 2000-04-27
CN1107497C (zh) 2003-05-07
US5851547A (en) 1998-12-22
CA2139058C (en) 2004-11-16
PT659406E (pt) 2000-06-30
EP0659406B1 (en) 2000-03-22
AU1280995A (en) 1995-07-17
ES2146633T3 (es) 2000-08-16
JP3720386B2 (ja) 2005-11-24
JPH07187994A (ja) 1995-07-25
KR100349960B1 (ko) 2003-03-06
CN1142763A (zh) 1997-02-12
AU686713B2 (en) 1998-02-12
NZ277548A (en) 1997-05-26
EP0659406A2 (en) 1995-06-28
CA2139058A1 (en) 1995-06-28
ATE190836T1 (de) 2000-04-15
EP0659406A3 (en) 1995-11-15

Similar Documents

Publication Publication Date Title
DK0659406T3 (da) Lægemiddelformulering med reguleret afgivelse
AU6050594A (en) Controlled release drug delivery device
GEP20022833B (en) New Controlled Release Bead, Method of Producing the Same and Multiple Unit Formulation Comprising It
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
CA2203901A1 (en) Polymeric wound healing accelerators
CA2161950A1 (en) Subdermally Implantable Device
MX9700850A (es) Formulaciones y metodos para proporcionar anestesia local prolongada.
NZ235807A (en) Controlled release pellet formulation (core coated with or comprising a glucocorticosteroid, and a polymeric outer coating); capsules containing pellets; and use in treating bowel disease
WO2001083398A3 (de) System für die freisetzung von wirkstoffen
DK1112739T3 (da) Langtidsafgivende depot-præparat
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
ES491307A0 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
EP0262893A3 (en) Ocular insert
GB9112495D0 (en) Improved formulations of acetazolamide
ZW7482A1 (en) Oxazole derivatives
MX9205982A (es) Agente para la preparacion de fibras, degradable biologicamente.
AU8168294A (en) Solid insecticidal formulation
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer
BRPI9607752B8 (pt) formulação farmacêutica de microcápsula de liberação controlada.
FR2757665B1 (fr) Dispositif autonome, notamment dispositif medical implantable actif, et son programmateur externe, a ajustement dynamique de la puissance d'emission
NZ337208A (en) sustained release pharmaceutical composition containing both slow release and fast release mini-granules coated with dexfenfluramine
ATE219911T1 (de) Prothetische gelenkpfanne